drugset / Trial / NCT04626258

Fluconazol Versus Medical Honey in the Treatment of Recurrent Vulvovaginal Candidiasis

NCT04626258

Phase 4 Unknown 252 enrolled Maastricht University Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the efficacy of Flucanzol versus L-mesitran in the treatment of patients with recurrent vulvovaginal candidiasis. The investigator will look at vaginal swabs after 1, 6 and 12 months. The investigator included 252 patients.

Timeline

Start
2021-03-01
Primary completion
2024-03-01
Completion
2025-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluconazole Small molecule 150 mg